Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Kebede H Begna

64PUBLICATIONS
178CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingHaematological tumoursPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

Sort by Publication Date:
|Apr 06, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients.

Saubia Fathima, Lior Rokach, Nour Ghosoun

|Sep 03, 2025
Triple A Plus (AAA <sup>+</sup>) Survival Prediction Model for Essential Thrombocythemia: Analysis Involving 7308 Patients.

Ayalew Tefferi, Giuseppe G Loscocco, Lior Rokach

|Jun 24, 2025
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes.

Clifford M Csizmar, Anuya Natu, Mark Gurney

|May 22, 2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

|Mar 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

Pageof 11

Frequent Collaborators

46 joint publications

Naseema Gangat

45 joint publications

Ayalew Tefferi

42 joint publications

Mrinal S Patnaik

33 joint publications

Aref Al-Kali

27 joint publications

Mark R Litzow

24 joint publications

Animesh Pardanani

22 joint publications

Mithun Vinod Shah

17 joint publications

Talha Badar

17 joint publications

Michelle Elliott

15 joint publications

Rong He

Frequent Collaborators

46 joint publications

Naseema Gangat

45 joint publications

Ayalew Tefferi

42 joint publications

Mrinal S Patnaik

33 joint publications

Aref Al-Kali

Top Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

1.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

374
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on : Oct 15, 2018

8.3K
See more related videos

Top Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

1.9K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

374
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
10:33

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase

Published on : Oct 15, 2018

8.3K
See more related videos